0000899243-21-035687.txt : 20210913 0000899243-21-035687.hdr.sgml : 20210913 20210913165607 ACCESSION NUMBER: 0000899243-21-035687 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210819 FILED AS OF DATE: 20210913 DATE AS OF CHANGE: 20210913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yoon Gene CENTRAL INDEX KEY: 0001814482 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39326 FILM NUMBER: 211250286 MAIL ADDRESS: STREET 1: C/O BREGAL INVESTMENTS, INC. STREET 2: 277 PARK AVENUE, 29TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10172 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Open Lending Corp CENTRAL INDEX KEY: 0001806201 STANDARD INDUSTRIAL CLASSIFICATION: PERSONAL CREDIT INSTITUTIONS [6141] IRS NUMBER: 823008583 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1501 S. MOPAC EXPRESSWAY STREET 2: SUITE #450 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 512-892-0400 MAIL ADDRESS: STREET 1: 1501 S. MOPAC EXPRESSWAY STREET 2: SUITE #450 CITY: AUSTIN STATE: TX ZIP: 78746 FORMER COMPANY: FORMER CONFORMED NAME: Nebula Parent Corp. DATE OF NAME CHANGE: 20200310 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-08-19 2021-08-23 0 0001806201 Open Lending Corp LPRO 0001814482 Yoon Gene C/O BREGAL INVESTMENTS, INC. 277 PARK AVENUE, 29TH FLOOR NEW YORK NY 10172 1 0 1 0 Common Stock 2021-08-19 4 S 0 500000 31.40 D 8786192 I See Footnote Common Stock 2021-08-20 4 S 0 264780 31.50 D 8521412 I See Footnote Common Stock 2021-08-20 4 S 0 65220 33.3269 D 8456192 I See Footnote The shares reported herein are held directly by Bregal Sagemount I, L.P. ("Bregal Sagemount"). The Reporting Person is the director of Bregal Investments, Inc. ("Bregal Investments"), which is the registered investment advisor of Bregal Sagemount. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares for Section 16 of the Securities Exchange Act of 1934 or any other purposes. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.48 to $33.26, inclusive. This amendment is being filed in order to amend the number of shares reflected in Table I, Column 5, Rows 2 and 3 for the sales of Common Stock on 8/20/2021. The information reported in the original Form 4, filed with the Securities & Exchange Commission on August 23, 2021, is otherwise correct in all respects. /s/ Gene Yoon 2021-09-13